ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
Health Canada has recently granted market authorization to Hoffman La-Roche Limited for their neuromyelitis optica spectrum disorder treatment, ENSPRYNG. Canada is the first country to offer this medication, and hopefully…